Atherosclerotic occlusive disease of the lower extremities (ASO-LE) has the third highest rate among systematic atherosclerosis obliterans, ranking after coronary heart disease and stoke, and the disease burden of ASO-LE has been continuously increasing.Invasive revascularizations, which is presented by endovascular therapy technique, has undergone a dramatic development in the past couples of decades.However, controversy concerned about the surgical management and operative indications has heated up in the meanwhile.Thus Society for Vascular Surgery (SVS) published the practice guidelines for ASO-LE with asymptomatic disease and claudication in March, 2015.At the first time the guideline definitely opposed the aggressive invasive revascularization for ASO-LE patients with asymptomatic disease or claudication under satisfied tolerance.Instead, it posed the extreme emphasis on the pharmacotherapy with risk reduction of atherosclerosis at the core and the exercise therapy with supervised or home-based exercise program at the core for ASO-LE patients with asymptomatic disease and claudication.%下肢动脉硬化闭塞症(ASO-LE)是仅次于冠心病和脑卒中的第三大动脉粥样硬化性疾病,并造成越来越重的疾病负担.侵入性血管重建技术尤其是腔内治疗技术得到了快速发展,但也随之带来越来越多治疗选择以及手术指征把握的问题.美国血管外科学会(SVS)2015年发布了无症状性及间歇性跛行ASO-LE的临床诊治指南,首次明确不主张对无症状性或耐受良好的跛行患者施行预防性的侵入性血管重建,强调了以控制动脉粥样硬化危险因素为核心的药物治疗方案以及以运动治疗为核心的功能锻炼方案的重要性.
展开▼
